Immunoreactivity of Ki-67 and ERβ was predominantly detected in the nuclei of carcinoma cells (Figure 2), the average labeling index across the whole cohort and the tumor stage were summarized in Figure 3. The gene discussed is ESR2; the disease is carcinoma.